Advertisement

Picture Berlin Partner Top News CareSyntax Raises $180m Funding 650x100px

News > All

Total search results: 854 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve. 2024-09-11
BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. 2024-08-22
Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. 2024-08-20
Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. 2024-08-20
Bavarian Nordic A/S. (8/8/24). "Press Release: Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production". Copenhagen. 2024-08-08
Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. 2024-08-05
Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. 2024-07-22
Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. 2024-07-17
Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. 2024-07-16
Bico Group AB. (7/10/24). "Press Release: Andréas Joersjö Appointed as General Counsel for Bico Group AB". 2024-07-10
HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. 2024-07-10
SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. 2024-07-09
Myricx Pharma Ltd.. (7/8/24). "Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development". London. 2024-07-08
Genovis AB. (7/4/24). "Press Release: Genovis Completes a Strategic Investment in Sequrna, a Developer of Next-generation RNase Inhibitors". Ghent. 2024-07-04
Forbion Capital Partners. (6/20/24). "Press Release: Forbion Announces First Close of Its New BioEconomy Fund I – Backing Biotech-enabled Companies Aiming to Impact the Future of Our Planet". Amsterdam. 2024-06-20
Hikma Pharmaceuticals plc. (6/17/24). "Press Release: Hikma Acquires Xellia’s Differentiated Portfolio and Enhances Injectables Pipeline, Manufacturing Capabilities and R&D". London. 2024-06-17
Coulter Partners. (6/12/24). "Press Release: Coulter Partners Announces Leadership Transition and Senior Leadership Team (SLT) Reorganization: Co-founder Bianca Coulter Becomes Executive Chair, Nicholas Green Appointed CEO". 2024-06-12
Moleculent AB. (6/11/24). "Press Release: Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication". Stockholm. 2024-06-11
Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge. 2024-06-10
Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. 2024-06-03
BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo. 2024-05-29
Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. 2024-05-29
Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". 2024-05-28
Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. 2024-05-28
Cellugy. (5/21/24). "Press Release: Danish Industrial Biotechnology Startup Cellugy Raises €4.9M to Replace Petrochemicals in Personal Care Products". Søborg. 2024-05-21
Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. 2024-05-15
ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. 2024-05-13
H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck". 2024-05-13
Commit Biologics ApS. (5/9/24). "Press Release: Commit Biologics Launches with €16m Seed Financing to Pioneer Complement System Activation to Treat Cancer and Autoimmune Disease". Aarhus. 2024-05-09
Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. 2024-05-07
Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. 2024-04-17
Nanoform Finland Oyj. (4/11/24). "Press Release: Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan". Helsinki. 2024-04-11
Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. 2024-04-03
Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen. 2024-03-26
CMS Hasche Sigle. (3/26/24). "Press Release: CMS Advises Sellers of Cardior Pharmaceuticals on Potential Acquisition by Novo Nordisk". Munich. 2024-03-26
Cardior Pharmaceuticals GmbH. (3/25/24). "Press Release: Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease". Bagsværd & Hannover. 2024-03-25
Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. 2024-03-21
Bico Group AB. (3/15/24). "Press Release: Founders Leave after Eight Years". 2024-03-15
Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. 2024-03-14
Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund. 2024-03-14
Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich. 2024-03-14
Fida Biosystems ApS. (3/13/24). "Press Release: In-Solution Kinetics by Fida Biosystems – Redefining Drug Interaction Analysis for Therapeutic Discovery". Copenhagen. 2024-03-13
Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC". 2024-02-29
InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. 2024-02-22
Commit Biologics ApS. (2/14/24). "Press Release: Commit Biologics Receives Innobooster Grant from Innovation Fund Denmark Funding". 2024-02-14
FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. 2024-02-07
Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". 2024-02-01
Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. 2024-01-30
BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. 2024-01-30
BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. 2024-01-24
IMU Bioscience (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. 2024-01-24
Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA. 2024-01-08
Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA. 2024-01-04
Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt. 2024-01-04
Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan. 2024-01-03
UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". 2023-12-21
Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads". 2023-12-20
LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. 2023-12-19
Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto. 2023-12-12
Freya Biosciences. (12/12/23). "Press Release: Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies". Copenhagen. 2023-12-12
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". 2023-12-05
AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". 2023-11-28
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". 2023-11-21
InDex Pharmaceuticals Holding AB. (11/21/23). "Press Release: InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program". 2023-11-21
Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra". 2023-11-21
Da Vinci Labs. (11/20/23). "Press Release: The European ‘SynBee Pitch Competition’ Will Reward Innovative Synthetic Biology Projects at SynBee Day 2024. Da Vinci Labs Is the New Coordinator of the SynBee Project". Reugny. 2023-11-20
NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. 2023-11-15
Bico Group AB. (11/13/23). "Press Release: Maria Forss Assumes Office as BICO’s CEO and President on November 20, 2023". 2023-11-13
Bico Group AB. (11/13/23). "Press Release: BICO Has Divested Ginolis through a Management Buy-out to Ginolis’ Current CEO Kauko Väinämö. The Purchase Price amounted to €1". 2023-11-13
VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam. 2023-11-13
AstraZeneca plc. (11/9/23). "Press Release: AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity [This press release is intended for investors and business / science media]". 2023-11-09
Kynexis B.V.. (11/7/23). "Press Release: Kynexis Launched to Advance Precision Therapeutics for Brain Diseases". Naarden. 2023-11-07
Nanoform Finland Oyj. (10/23/23). "Press Release: Nanoform Grant Global Starmap AI License to AstraZeneca". Helsinki. 2023-10-23
High-Tech Gründerfonds Management GmbH. (10/23/23). "Press Release: FarmInsect Raises Oversubscribed €8m Series A to Commercially Scale Its Insect Farming Technology". Munich. 2023-10-23
Thermo Fisher Scientific Inc.. (10/17/23). "Press Release: Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics". Waltham, MA & Uppsala. 2023-10-17
Lundbeckfonden. (10/16/23). "Press Release: Venture Forces Invest Millions in New Type of Treatment for Particularly Aggressive Form of Cancer". 2023-10-16
CombiGene AB. (10/14/23). "Press Release: Spark Therapeutics Terminates Collaboration Agreement for the Epilepsy Project CG01 with CombiGene". Stockholm. 2023-10-14
Bico Group AB. (10/11/23). "Press Release: Cellink and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence". San Diego, CA. 2023-10-11
Agomab Therapeutics N.V.. (10/10/23). "Press Release: Agomab Raises $100 Million Series C to Advance Fibrosis-focused Pipeline". Ghent. 2023-10-10
Circio Holding ASA. (10/10/23). "Press Release: Circio and Neoregen Biotech Enter Collaboration for Delivery of Novel Circular RNA Therapeutics Using NICT technology". 2023-10-10
LimmaTech Biologics AG. (10/9/23). "Press Release: LimmaTech Biologics Raises $37 Million Series A to Advance Its Pipeline of Vaccines Against Multidrug-Resistant Bacterial Infections". Schlieren. 2023-10-09
AstronauTx Ltd.. (10/9/23). "Press Release: AstronauTx Closes £48 Million ($61 Million) Series A Financing to Create New Treatments for Alzheimer’s Disease". London. 2023-10-09
EBD Group. (10/4/23). "Press Release: BIO-Europe Set to Break Records in Munich, Germany". Munich. 2023-10-04
PolyPeptide Group AG. (10/2/23). "Press Release: PolyPeptide Secures Revolving Credit Facility". Baar. 2023-10-02
Evosep ApS. (9/28/23). "Press Release: Evosep Strengthens Leadership to Drive Scale-up". Odense. 2023-09-28
AAX Biotech AB. (9/28/23). "Press Release: AAX Biotech Welcomes New CEO to Drive Advancements in Next-generation Antibody Therapeutics". 2023-09-28
Acesion Pharma ApS. (9/26/23). "Press Release: Acesion Pharma Closes Oversubscribed €45M Series B Financing Round". Copenhagen. 2023-09-26
Novo Nordisk A/S. (9/25/23). "Press Release: Valo Health and Novo Nordisk to Collaborate to Discover and Develop Novel Treatments for Cardiometabolic Diseases Using Human Data and Artificial Intelligence". Bagsværd & Boston, MA. 2023-09-25
Traceless Materials GmbH. (9/25/23). "Press Release: Traceless Materials Secures €36.6 Million Series A to Build First Industry Plant for Bio-circular Alternative to Plastic". Hamburg. 2023-09-25
Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. 2023-09-18
Lauxera Capital Partners. (9/12/23). "Press Release: Lauxera Capital Partners Invests €17 Million in Swedish Regenerative Medicine Leader BioLamina AB". Paris & San Francisco, CA. 2023-09-12
Qiagen N.V.. (9/11/23). "Press Release: Qiagen Launches API to Streamline Access to World-leading Biomedical Data for AI Integration". Venlo & Redwood City, CA. 2023-09-11
Proteros Biostructures GmbH. (9/6/23). "Press Release: Proteros Biostructures and Orion Pharma Agree on a Long-term Multi-target Collaboration". Martinsried. 2023-09-06
Illumina, Inc.. (9/5/23). "Press Release: Illumina's Board Appoints Jacob Thaysen, Ph.D. as its New Chief Executive Officer". San Diego, CA. 2023-09-05
BioInnovation Institute (BII). (9/4/23). "Press Release: Six Companies Enter BioInnovation Institute’s Venture House Program Receiving Additional Financial Support". 2023-09-04
ECBF Management GmbH. (9/4/23). "Press Release: 23 Million Euros for Sustainable Packaging Materials. ECBF Leads Paptic Financing Round". Luxembourg. 2023-09-04
Embark Laboratories ApS. (8/30/23). "Press Release: Novo Nordisk Acquires Embark Biotech, including Its Lead Asset Targeting Obesity and other Cardiometabolic Diseases". Copenhagen. 2023-08-30
CEPI. (8/29/23). "Press Release: CEPI and University of Oxford to Accelerate Vaccine Development against Disease X". Oslo & Oxford. 2023-08-29
Bico Group AB. (8/21/23). "Press Release: Bico Announces Goodwill Impairment Predominantly Due to Increased WACC, and Write-downs of Assets". 2023-08-21
Bico Group AB. (8/21/23). "Press Release: Maria Forss Is Appointed New President and CEO of Bico Group AB (publ)". 2023-08-21
1 2 3 4 5 6 7 8 9  next pagenext page



Advertisement

Picture EBD Group BIO-Europe 2024 Stockholm from 14 Sep 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x200px

» top